Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 10.59% is 432% above its 5-year average of 1.99%, near the high end of its 5-year range (-9.66%–10.59%).
1257.38% above its 12-month average of -0.92%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
10.59%
RETURN ON ASSETS (ROA) AVG TTM
-0.92%
RETURN ON ASSETS (ROA) AVG 3Y
3.28%
RETURN ON ASSETS (ROA) AVG 5Y
1.99%
RETURN ON ASSETS (ROA) AVG 10Y
4.53%
RETURN ON ASSETS (ROA) AVG 15Y
7.59%
RETURN ON ASSETS (ROA) AVG 20Y
8.29%
CURRENT VS TTM AVG
+1257.38%
CURRENT VS 3Y AVG
+222.62%
CURRENT VS 5Y AVG
+432.16%
CURRENT VS 10Y AVG
+133.92%
CURRENT VS 15Y AVG
+39.45%
CURRENT VS 20Y AVG
+27.73%
SECTOR MEDIAN · HEALTHCARE
5.14%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+106.03%
vs the sector median at left
Bristol-Myers Squibb Company
Market Cap
$132.14B
Return on Assets (ROA)
10.59%
TTM Avg
-0.92%
3Y Avg
3.28%
5Y Avg
1.99%
Market Cap
$134.24B
Return on Assets (ROA)
16.06%
TTM Avg
6.37%
3Y Avg
11.74%
5Y Avg
14.58%
Market Cap
$123.70B
Return on Assets (ROA)
15.04%
TTM Avg
13.09%
3Y Avg
12.00%
5Y Avg
11.68%
Market Cap
$122.58B
Return on Assets (ROA)
1.93%
TTM Avg
1.25%
3Y Avg
1.93%
5Y Avg
2.38%
Market Cap
$144.25B
Return on Assets (ROA)
4.33%
TTM Avg
4.68%
3Y Avg
5.89%
5Y Avg
6.01%
Market Cap
$118.26B
Return on Assets (ROA)
410.52%
TTM Avg
5.13%
3Y Avg
4.62%
5Y Avg
4.65%
Market Cap
$105.97B
Return on Assets (ROA)
7.78%
TTM Avg
6.88%
3Y Avg
7.02%
5Y Avg
6.41%
Market Cap
$104.10B
Return on Assets (ROA)
5.20%
TTM Avg
5.08%
3Y Avg
5.08%
5Y Avg
2.52%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bristol-Myers Squibb Company (BMY) | $132.14B | 10.59% | -0.92% | 3.28% | 1.99% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $134.24B | 16.06% | 6.37% | 11.74% | 14.58% |
| Intuitive Surgical, Inc. (ISRG)vs › | $123.70B | 15.04% | 13.09% | 12.00% | 11.68% |
| CVS Health Corp. (CVS)vs › | $122.58B | 1.93% | 1.25% | 1.93% | 2.38% |
| Danaher Corporation (DHR)vs › | $144.25B | 4.33% | 4.68% | 5.89% | 6.01% |
| Medtronic plc (MDT)vs › | $118.26B | 410.52% | 5.13% | 4.62% | 4.65% |
| Stryker Corporation (SYK)vs › | $105.97B | 7.78% | 6.88% | 7.02% | 6.41% |
| Pfizer Inc. (PFE)vs › | $158.39B | 2.16% | 3.75% | 6.08% | 7.08% |
| McKesson Corporation (MCK)vs › | $104.10B | 5.20% | 5.08% | 5.08% | 2.52% |
| Sanofi (SNY)vs › | $103.62B | 3.12% | 5.18% | 5.31% | 6.19% |
ROA
10.6%
ROE
41.6%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 7.83% |
| 2024-12-31 | -9.66% |
| 2023-12-31 | 8.43% |
| 2022-12-31 | 6.53% |
| 2021-12-31 | 6.40% |
| 2020-12-31 | -7.59% |
| 2019-12-31 | 2.65% |
| 2018-12-31 | 14.06% |
| 2017-12-31 | 3.00% |
| 2016-12-31 | 13.22% |
| 2015-12-31 | 4.93% |
| 2014-12-31 | 5.94% |
| 2013-12-31 | 6.64% |
| 2012-12-31 | 5.46% |
| 2011-12-31 | 11.25% |
| 2010-12-31 | 9.98% |
| 2009-12-31 | 34.22% |
| 2008-12-31 | 17.79% |
| 2007-12-31 | 8.27% |
| 2006-12-31 | 6.20% |
| 2005-12-31 | 10.66% |
| 2004-12-31 | 7.85% |
| 2003-12-31 | 11.32% |
| 2002-12-31 | 8.54% |
| 2001-12-31 | 17.38% |
| 2000-12-31 | 26.80% |
| 1999-12-31 | 24.35% |
| 1998-12-31 | 19.30% |
| 1997-12-31 | 21.40% |
| 1996-12-31 | 19.41% |
